New Key Statistics Module, Z-Score and F-Score
SZSE:301246 Key Ratios
Market Cap ¥ M | 5,544.09 |
Enterprise Value ¥ M | 4,108.54 |
P/E(ttm) | 111.77 |
PE Ratio without NRI | 86.63 |
Forward PE Ratio | -- |
Price/Book | 1.26 |
Price/Sales | 2.77 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | 0.63 |
Revenue (TTM) ¥ M | 1,977.00 |
EPS (TTM) ¥ | 0.12 |
Beneish M-Score | -1.93 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 13.80 |
y-y EBITDA Growth Rate % | -81.90 |
EV-to-EBIT | 56.07 |
EV-to-EBITDA | 56.07 |
PEG | 6.28 |
Shares Outstanding M | 400.01 |
Net Margin (%) | 2.71 |
Operating Margin % | 3.00 |
Pre-tax Margin (%) | 2.93 |
Quick Ratio | 3.26 |
Current Ratio | 3.52 |
ROA % (ttm) | 0.94 |
ROE % (ttm) | 1.23 |
ROIC % (ttm) | 1.93 |
Dividend Yield % | 0.69 |
Altman Z-Score | 4.23 |
SZSE:301246 Number of Guru Trades
SZSE:301246 Volume of Guru Trades
Gurus Latest Trades with SZSE:301246
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301246 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Hubei Hongyuan Pharmaceutical Technology Co Ltd Insider Transactions
No Available Data